Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 22 von 117
Leukemia & lymphoma, 2010-10, Vol.51 (10), p.1793-1804
2010
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Multidrug resistance in the chronic lymphoproliferative disorders
Ist Teil von
  • Leukemia & lymphoma, 2010-10, Vol.51 (10), p.1793-1804
Ort / Verlag
United States: Informa UK Ltd
Erscheinungsjahr
2010
Quelle
MEDLINE
Beschreibungen/Notizen
  • Multidrug resistance (MDR) is a phenomenon in malignancy whereby tumor cells generate mechanisms to resist cytotoxic treatments. Several such mechanisms have been identified. However, to date the most significant research on MDR has involved the adenosine triphosphate binding cassette (ABC) transporter proteins, including P-glycoprotein (P-gp) and multidrug resistance associated protein (MRP). These proteins have natural functions involving substrate transport in normal cells but are detrimental to treatment when expressed in the membrane of tumor cells. It remains unclear whether ABC mediated MDR functions primarily through protein up-regulation or via a relevant signaling mechanism, or is simply due to selective pressure on an already resistant tumor cell subpopulation. Here we present an overview of MDR in the chronic lymphoproliferative disorders (CLPDs), in particular that attributed to the ABC transporter protein family.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX